Plant-Based Vaccines Global Market Report 2024

Description

Plant-based vaccines are recombinant vaccines that utilize antigens against specific infections incorporated into selected plants. These vaccines offer an effective means of treating various human and animal diseases.

The primary types of plant-based vaccines include bacterial vaccines, viral vaccines, parasite vaccines, and others. Bacterial vaccines involve preparations of either dead or weakened bacteria utilized as active immunizing agents. Various plant sources, including tobacco plants, maize, and potatoes, are employed for this purpose. Plant-based vaccines find applications in addressing diseases such as influenza, Zika virus, Ebola virus, poultry diseases, and others.

The plant-based vaccines market research report is one of a series of new reports from The Business Research Company that provides plant-based vaccines market statistics, including plant-based vaccines industry global market size, regional shares, competitors with a plant-based vaccines market share, detailed plant-based vaccines market segments, market trends, and opportunities, and any further data you may need to thrive in the plant-based vaccines industry. This plant-based vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The plant-based vaccines market size has grown rapidly in recent years. It will grow from $1.52 billion in 2023 to $1.68 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The growth observed in the historical period can be attributed to several factors, including traditional challenges in vaccine production, the demand for cost-effective vaccine production methods, the emergence of plant molecular farming as an innovative approach, the potential for reduced allergenicity, and applications of synthetic biology in vaccine development.

The plant-based vaccines market size is expected to see rapid growth in the next few years. It will grow to $2.5 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%. The anticipated growth in the forecast period can be attributed to factors such as increased emphasis on pandemic preparedness, global health security concerns, the expansion of vaccine applications, and the adoption of plant-based vaccines by the pharmaceutical industry. Major trends expected in the forecast period include technological advancements in plant biotechnology, a focus on environmental sustainability in vaccine production, and the integration of artificial intelligence (AI) and machine learning (ML) technologies in vaccine development processes.

The plant-based vaccine market is expected to experience significant growth due to the high prevalence of infectious diseases. Infectious diseases, caused by various germs such as bacteria, viruses, fungi, or parasites, remain a global health concern. Plant-based vaccines have emerged as secure, effective, and affordable solutions for preventing and treating various infectious diseases. For example, the World Health Organization's Global Tuberculosis Report in October 2022 revealed an estimated 10.6 million cases of tuberculosis (TB) globally, emphasizing the need for effective vaccination strategies. The plant-based vaccine market is thus being driven by the imperative to address the substantial burden of infectious diseases.

The growth of the plant-based vaccine market is further fueled by the rising demand for personalized medicine. Personalized medicine, which tailors medical treatments based on an individual's unique genetic makeup, has become a prominent approach for more effective healthcare interventions. Plant-based vaccines are integral to this personalized medicine paradigm, offering the potential for safer and more effective immunotherapies. The ability to customize vaccine components based on individual genetic profiles enhances the precision and efficacy of treatments. With 34% of new molecular entities (NMEs) approved by the Food and Drug Administration's Center for Drug Evaluation and Research in 2022 classified as personalized medicines, the demand for personalized medicine is a key driver for the plant-based vaccine market.

Government funding for vaccine development is a significant factor propelling the growth of the plant-based vaccine market. Governments worldwide are investing in vaccine development to address various health challenges, including the COVID-19 pandemic. Funding initiatives support the research, development, and production of vaccines, including plant-based options. An example is the U.S. Department of Health and Human Services introducing a $350 million initiative to enhance COVID-19 vaccine distribution, emphasizing the importance of government support in advancing vaccine development.

Product innovation is a notable trend in the plant-based vaccine market, with major companies focusing on developing groundbreaking products to maintain their market positions. In February 2022, Medicago Inc. and GSK PLC announced the approval of COVIFENZ, the first plant-based COVID-19 vaccine by Health Canada. COVIFENZ utilizes coronavirus-such as particle (CoVLP) technology, representing an innovative approach to vaccine development.

Companies in the plant-based vaccine market are also adopting advanced solutions such as plant-technology platforms to optimize scalability, enhance efficacy, and streamline manufacturing processes. Utilizing plant systems for efficient vaccine production and development, British American Tobacco launched KBio Holdings Limited (KBio) in January 2022. KBio aims to leverage its plant-based technology platform to expedite research, development, and production of novel treatments for rare and infectious diseases, showcasing the potential of plant-based production systems in terms of speed, scale-up capability, and thermostability.

Major companies operating in the plant-based vaccines market report are Sanofi Pasteur SA, GlaxoSmithKline plc., British American Tobacco PLC, ICON Plc., Agenus Inc., Medicago Inc., Panacea Biotec Limited, Creative Biolabs Inc., InVitria, Fraunhofer USA Inc., Biodextris Inc., Intravacc B.V, Avesthagen Limited, Calyxt Inc., Zyus Life Sciences Inc., Mapp Biopharmaceutical Inc., Entos Pharmaceuticals Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, Synbiotic Health Inc., Altimmune Inc., Oramed Pharmaceuticals Inc., iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG

North America was the largest region in the plant-based vaccines market in 2023. The regions covered in the plant-based vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the plant-based vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The plant-based vaccines market consists of sales of cholera vaccines and norovirus vaccines. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Plant-Based Vaccines Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on plant-based vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for plant-based vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The plant-based vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Vaccine Type: Bacterial Vaccines; Viral Vaccines; Parasite Vaccines; Other Vaccine Types
2) By Source: Tobacco Plant; Maize; Potato; Other Sources
3) By Application: Influenza; Zika Virus; Ebola Virus; Poultry Disease; Other Applications
Companies Mentioned: Sanofi Pasteur SA; GlaxoSmithKline plc.; British American Tobacco PLC; ICON Plc.; Agenus Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r13812

1. Executive Summary

2. Plant-Based Vaccines Market Characteristics

3. Plant-Based Vaccines Market Trends And Strategies

4. Plant-Based Vaccines Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Plant-Based Vaccines Market Size and Growth

5.1. Global Plant-Based Vaccines Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Plant-Based Vaccines Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Plant-Based Vaccines Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Plant-Based Vaccines Market Segmentation

6.1. Global Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Bacterial Vaccines
Viral Vaccines
Parasite Vaccines
Other Vaccine Types
6.2. Global Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Tobacco Plant
Maize
Potato
Other Sources
6.3. Global Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Influenza
Zika Virus
Ebola Virus
Poultry Disease
Other Applications

7. Plant-Based Vaccines Market Regional And Country Analysis

7.1. Global Plant-Based Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Plant-Based Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Plant-Based Vaccines Market

8.1. Asia-Pacific Plant-Based Vaccines Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Plant-Based Vaccines Market

9.1. China Plant-Based Vaccines Market Overview
9.2. China Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Plant-Based Vaccines Market

10.1. India Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Plant-Based Vaccines Market

11.1. Japan Plant-Based Vaccines Market Overview
11.2. Japan Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Plant-Based Vaccines Market

12.1. Australia Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Plant-Based Vaccines Market

13.1. Indonesia Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Plant-Based Vaccines Market

14.1. South Korea Plant-Based Vaccines Market Overview
14.2. South Korea Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Plant-Based Vaccines Market

15.1. Western Europe Plant-Based Vaccines Market Overview
15.2. Western Europe Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Plant-Based Vaccines Market

16.1. UK Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Plant-Based Vaccines Market

17.1. Germany Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Plant-Based Vaccines Market

18.1. France Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Plant-Based Vaccines Market

19.1. Italy Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Plant-Based Vaccines Market

20.1. Spain Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Plant-Based Vaccines Market

21.1. Eastern Europe Plant-Based Vaccines Market Overview
21.2. Eastern Europe Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Plant-Based Vaccines Market

22.1. Russia Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Plant-Based Vaccines Market

23.1. North America Plant-Based Vaccines Market Overview
23.2. North America Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Plant-Based Vaccines Market

24.1. USA Plant-Based Vaccines Market Overview
24.2. USA Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Plant-Based Vaccines Market

25.1. Canada Plant-Based Vaccines Market Overview
25.2. Canada Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Plant-Based Vaccines Market

26.1. South America Plant-Based Vaccines Market Overview
26.2. South America Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Plant-Based Vaccines Market

27.1. Brazil Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Plant-Based Vaccines Market

28.1. Middle East Plant-Based Vaccines Market Overview
28.2. Middle East Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Plant-Based Vaccines Market

29.1. Africa Plant-Based Vaccines Market Overview
29.2. Africa Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Plant-Based Vaccines Market Competitive Landscape And Company Profiles

30.1. Plant-Based Vaccines Market Competitive Landscape
30.2. Plant-Based Vaccines Market Company Profiles
- 30.2.1. Sanofi Pasteur SA
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. GlaxoSmithKline plc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. British American Tobacco PLC
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. ICON Plc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Agenus Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Plant-Based Vaccines Market Other Major And Innovative Companies

31.1. Medicago Inc.
31.2. Panacea Biotec Limited
31.3. Creative Biolabs Inc.
31.4. InVitria
31.5. Fraunhofer USA Inc.
31.6. Biodextris Inc.
31.7. Intravacc B.V
31.8. Avesthagen Limited
31.9. Calyxt Inc.
31.10. Zyus Life Sciences Inc.
31.11. Mapp Biopharmaceutical Inc.
31.12. Entos Pharmaceuticals Inc.
31.13. Kentucky BioProcessing Inc.
31.14. Planet Biotechnology Inc.
31.15. Icon Genetics GmbH

32. Global Plant-Based Vaccines Market Competitive Benchmarking

33. Global Plant-Based Vaccines Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Plant-Based Vaccines Market

35. Plant-Based Vaccines Market Future Outlook and Potential Analysis

35.1 Plant-Based Vaccines Market In 2028 - Countries Offering Most New Opportunities
35.2 Plant-Based Vaccines Market In 2028 - Segments Offering Most New Opportunities
35.3 Plant-Based Vaccines Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer